We’re in the News - BISA Quoted in MedTech Dive on Dr. Michelle Tarver’s Appointment as New FDA CDRH Director
BISA’s president Maria Gmitro and BISA’s advisor data advocate Madris Kinard of Device Events were both quoted in MedTech Dive, citing the optimism regarding Dr. Michelle Tarver’s appointment as the new Director of CDRH at FDA.
Test Your Knowledge! Take BISA’s Breast Implant Safety Quiz
BISA wants to keep women healthy, safe, and informed. How much do YOU really know about breast implants? Test you knowledge by taking our short quiz.
Is BIA-ALCL a Common Risk of Exposure to Allergan Biocell® Implants?
Breast Implant Associated Lymphoma (BIA-ALCL) is a type of non-Hodgkin's lymphoma, a cancer of the immune system. Accumulating evidence suggests that BIA-ALCL may be a common—not rare—risk from exposure to Allergan Biocell® breast implants.